Martine Lamfers

Happy to share our latest work by Verheul, Fabro etal, describing our optimized protocol for establishing GBM cell cultures. Another step forward to personalized drugscreening for GBM patients! Thank you to everyone who contributed.🙏𝗡𝗮𝘁𝘂𝗿𝗲 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆(2025)
🔗 www.nature.com/articles/s41...

Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological Studies Background and Objective: Access to high-quality patient-derived brain tumor tissues is instrumental for translational neuro-oncology research. Glioblastoma tumor material resected by ultrasonic aspir...

Don’t discard the ultrasonic aspirate from brain tumor surgeries!
In our latest paper we describe the rich source it offers for isolating immune cell populations from glioblastoma tissue.
Great work by former PhD students Effie Stavrakaki and Zineb Belcaid.
www.mdpi.com/2072-6694/17...

“Scientists should embrace their humanity rather than pretending that they are a bunch of automatons who instantly reach perfectly objective conclusions”

HEEL NEDERLAND GAAT WEG BIJ X

X is een broeinest van desinformatie geworden. Tijd voor DetoX! Teken de pledge en vertrek samen met ons van X #JanuariDetoX campagnes.degoedezaak.org/campaigns/de...

The scientist who tested his revolutionary medicine on his own brain cancer: ‘It seemed worth it to give it a crack’ Richard Scolyer was one of the world’s leading melanoma researchers when he was struck with a brain tumour. Facing likely death, his team made him a guinea pig for his own medicine

We are delighted to hear this update on Prof Scolyer's progress. A good news story in a field that can be very tough. More stratified clinical trials are needed to test immunotherapy options in glioblastoma. We hope to contribute to the growing pool of data that will support such trials🙏